IWC's Underlying Holdings Could Mean 14% Gain Potential

Looking at the underlying holdings of the ETFs in our coverage universe at ETF Channel, we have compared the trading price of each holding against the average analyst 12-month forward target price, and computed the weighted average implied analyst target price for the ETF itself. For the iShares Micro-Cap ETF (IWC), we found that the implied analyst target price for the ETF based upon its underlying holdings is $92.36 per unit.

START SLIDESHOW:
10 ETFs With Most Upside To Analyst Targets »

With IWC trading at a recent price near $80.94 per unit, that means that analysts see 14.11% upside for this ETF looking through to the average analyst targets of the underlying holdings. Three of IWC's underlying holdings with notable upside to their analyst target prices are Conatus Pharmaceuticals Inc ( CNAT), Genocea Biosciences Inc ( GNCA), and Anavex Life Sciences Corp ( AVXL). Although CNAT has traded at a recent price of $2.09/share, the average analyst target is 416.75% higher at $10.80/share. Similarly, GNCA has 332.80% upside from the recent share price of $4.39 if the average analyst target price of $19.00/share is reached, and analysts on average are expecting AVXL to reach a target price of $12.50/share, which is 289.41% above the recent price of $3.21. Below is a twelve month price history chart comparing the stock performance of CNAT, GNCA, and AVXL:

CNAT, GNCA, and AVXL Relative Performance Chart

Below is a summary table of the current analyst target prices discussed above:

Name Symbol Recent Price Avg. Analyst 12-Mo. Target % Upside to Target
iShares Micro-Cap ETF IWC $80.94 $92.36 14.11%
Conatus Pharmaceuticals Inc CNAT $2.09 $10.80 416.75%
Genocea Biosciences Inc GNCA $4.39 $19.00 332.80%
Anavex Life Sciences Corp AVXL $3.21 $12.50 289.41%

Are analysts justified in these targets, or overly optimistic about where these stocks will be trading 12 months from now? Do the analysts have a valid justification for their targets, or are they behind the curve on recent company and industry developments? A high price target relative to a stock's trading price can reflect optimism about the future, but can also be a precursor to target price downgrades if the targets were a relic of the past. These are questions that require further investor research.

More from Stocks

Week Ahead: Trade Fears and Stress Tests Signal More Volatility To Come

Week Ahead: Trade Fears and Stress Tests Signal More Volatility To Come

3 Great Stock Market Sectors Millennials Should Invest In

3 Great Stock Market Sectors Millennials Should Invest In

Why Millennials Are Ditching Stocks for ETFs

Why Millennials Are Ditching Stocks for ETFs

Trump's 'Space Force' Could Launch a $1 Trillion Industry, Morgan Stanley Says

Trump's 'Space Force' Could Launch a $1 Trillion Industry, Morgan Stanley Says

Abiomed Stock Should Rise Some 12% From Here, Piper Jaffray Analyst Says

Abiomed Stock Should Rise Some 12% From Here, Piper Jaffray Analyst Says